NCT00601510View on ClinicalTrials.gov

Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2012

Conditions
Gastric Cancer
Interventions
DRUG

capecitabine

DRUG

cisplatin

DRUG

imatinib mesylate

Trial Locations (1)

D-81675

Klinikum Rechts Der Isar - Technische Universitaet Muenchen, Munich

All Listed Sponsors
lead

Technical University of Munich

OTHER

NCT00601510 - Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer | Biotech Hunter | Biotech Hunter